Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Healthylife| Healthylife brand | |
| Prescription only | No Prescription Only Medicines CY0AA0 |
| Healthylife content | Healthylife Brand Brand |
| Medicare | No |
| Healthylife trackable | |
| Healthylife References | Burgdorff AJ, Dickson L, Krasinski J. Inhaler product information for children and adults with COPD. Pediatrics. 2006;113(1):25-34. View on: https://www.accessdata.fda.gov.au/utk/programme/ healthcare-data/2411/healthylife/programme/medicine/healthylife/medicine/healthylife-precautions.html. Accessed June 20, 2025. |
| Healthylife product | Healthylife product information |
Healthylife contains an affiliate program.
All products sold by Healthylife are provided on an independently owned website and may contain affiliate information. All products are subject to change and may be refunded. Healthylife does not authorize or authorize any third parties for any purpose.
Product InformationVentolin Salbutamol (100mcg) is a prescription only medication used to relieve symptoms of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Ventolin belongs to a group of drugs called bronchodilators. It works by relaxing the muscles in the airways and widening the airways allowing more airflow into the lungs.
Asthma is a chronic, airway-constriction condition causing breathing difficulties. Ventolin helps relieve symptoms such as shortness of breath, wheezing, coughing, chest tightness, and wheezing. It also reduces the frequency and severity of attacks.
Other respiratory conditions include bronchospasm (wheezing), cough (stuffy nose), difficulty breathing, and exercise-induced bronchospasm (e.g., cough with or without wheezing).
Asthma is a lung condition characterized by wheezing and shortness of breath. It is caused by a chemical imbalance in the body called asthma. Ventolin is used to relieve symptoms such as wheezing, coughing, chest tightness, and shortness of breath.
The Food and Drug Administration (FDA) has approved two new drugs to treat acute asthma and reduce the risk of death in patients with asthma, a new study shows.
The FDA has approved the drugs, Ventolin and Orexin, which contain the same active ingredients, which work in the same way in the lungs. In the past five years, Ventolin and Orexin have been the only medicines to treat patients with asthma and reduce the risk of death in asthma attacks.
The two medicines are designed to be used together, as part of a “combination asthma treatment,” which is similar to other respiratory medicine classes, such as steroids. Asthma, in particular, is a chronic condition that often affects a patient’s ability to breathe. For the patients with asthma, the combination is designed to help ease the symptoms of an acute attack by reducing inflammation and thickening the airways.
The combination is meant to be taken in the morning and taken on an empty stomach in the evening. The doctors must wait at least two hours before the medication is taken.
The FDA said it is not recommending the use of Orexin alone for the prevention of asthma attacks. But the agency has also approved the use of Ventolin, which is not associated with increased asthma attacks. The combination is also not indicated for the prevention of heart attacks.
“The FDA has not identified these adverse reactions and has not approved Ventolin and Orexin as a treatment for acute asthma,” said Steven Nissen, MD, director of the agency’s emergency medical services division.
Nissen said the safety and effectiveness of these medicines for the prevention of asthma has not been established. “Patients with asthma are at risk of developing asthma attacks in the first year of treatment, and therefore, they need to be closely monitored and treated,” he said.
The new drug studies will include eight studies, conducted in collaboration with Asthma Foundation researchers and researchers at the University of California, San Francisco, and the University of North Carolina. The trials will include patients who have had asthma attacks in the past five years, but not the earlier, which occurred in the previous two years.
The first trial, which involved 3,664 patients, was conducted by Dr. Taro, director of the University of California San Francisco’s asthma care program, and is to be conducted by the University of North Carolina’s researchers, which has been conducting these studies since 2002.
Nissen said the first trial of the new drug is to be conducted by a team of researchers from the University of North Carolina. They will conduct a randomized, double-blind study, which is to be conducted by the University of California, San Francisco, and which is expected to begin in May, with a follow-up date.
The trial will include 4,086 patients in an observational study. The patients will be randomly assigned to receive Ventolin, which is taken three times a day at home. The trial will take place in the first year, and all patients will be followed for six months.
Nissen said the trials will be done at the University of North Carolina’s College of Medicine’s College of Physicians and Surgeons.
“The goal of this trial is to provide information on the safety of Ventolin and Orexin, which are already used as treatments for asthma, and that they have the potential to be used in combination with other therapies for asthma,” he said. “To be able to identify which patients are at risk of asthma, the study will be conducted in one of the most sensitive and effective ways possible, with a high degree of frequency of reporting and accurate data.”
Nissen said the first trial was funded by Asthma Foundation researchers at the University of North Carolina. In the second trial, which involved 1,800 patients, Asthma Foundation researchers will conduct a randomized, double-blind trial.The trial will begin in the second year of the trial, and all patients will be followed for six months.
In the third trial, which involved more than 1,800 patients, the trial will enroll patients with asthma, and will include patients who have not been treated with asthma medications and have taken one or more of the two drugs at the same time. Patients will be randomized to receive either Ventolin, which is taken at home, or Orexin, which is taken in the morning or in the evening.
Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Medicare CardNo MedicareConcession
$19.95
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
VentolinSalbutamol (2mg/5ml)5ml Oral SolutionHealthylife contains 2 ml of Ventolin salbutamol 2mg/5ml in 10 ml oral solution. The amount of salbutamol in the oral solution is usually between 5 and 20 mg per 5 ml. Always use the oral solution with care and consult with a doctor before using this product.
When>$20.00
Healthylife supplies on demandThis product is on sale now!
Ventolin Salbutamol is a salbutamol bronchodilator used to treat bronchospasm in patients with asthma and exercise-induced bronchospasm in adults and children over 12 years of age. Ventolin Salbutamol works by relaxing muscles in the airways, thereby opening passages for increased airflow. Salbutamol belongs to a class of drugs known as selective beta2-adrenoceptor agonists. Ventolin Salbutamol works by binding to beta2 receptors in the airways, which increases the likelihood of asthma attacks. Ventolin Salbutamol is used to treat the symptoms of exercise-induced bronchospasm in adults and children 12 years of age and older. Ventolin Salbutamol is a selective beta2-adrenoceptor agonist that may work by blocking the actions of other medications in the body. Ventolin Salbutamol may also be used to treat exercise-induced pulmonary hemorrhage (e.g., pulmonary edema) in patients with congestive heart failure (CHF), stable angina, and other conditions that may increase exercise capacity. Ventolin Salbutamol may be used to treat certain types of exercise-induced pulmonary hemorrhage (e.g., exercise-induced pulmonary edema) in patients who are not candidates for other treatments for exercise-induced pulmonary hemorrhage (e.g., ventolin salbutamol 2mg/5ml). The active ingredient in Ventolin Salbutamol is salbutamol. Salbutamol works by relaxing muscles in the airways, thereby opening passages for increased airflow. Salbutamol belongs to a class of drugs known as selective beta-2-adrenoceptor agonists. Salbutamol works by binding to beta2-adrenoceptor receptors in the airways, which increases the likelihood of asthma attacks. Ventolin Salbutamol is also available in a generic formulation. Ventolin Salbutamol is supplied in 10 ml oral solution. Ventolin Salbutamol 2mg/5ml Oral Solution is intended for oral use only. Ventolin Salbutamol 2mg/5ml Oral Solution is not intended for immediate relief of asthma or exercise-induced bronchospasm symptoms.
Ventolin is a bronchodilator that is prescribed for the treatment of acute and chronic obstructive pulmonary disease (COPD), emphysema, and chronic bronchitis. Ventolin is a medication that contains salbutamol, a bronchodilator that works by relaxing muscles and increasing the flow of oxygenated blood to the airways. Salbutamol works by opening the breathing passages of the lungs, reducing the workload of the heart and the airways, and improving the quality of life for patients with these conditions. Ventolin is used to treat both acute and chronic obstructive pulmonary disease (COPD). Asthma is a chronic condition that causes shortness of breath, wheezing, or coughing. Asthma symptoms may include shortness of breath, cough, chest tightness, coughing up and down, and difficulty breathing. Ventolin is also used to treat asthma attacks that occur when the body cannot breathe. It is available over the counter and is a short-acting bronchodilator (SA):
If you have asthma, COPD, hives, or any other breathing problem, you should avoid using Ventolin and inhaled corticosteroids, or any other medication that contains salbutamol. Salbutamol, also known as salmeterol, is used to treat both acute and chronic obstructive pulmonary disease (COPD). It belongs to a class of medications called bronchodilators.
Salmeterol works by relaxing muscles in the airways, which allows the airways to open up and breathe more freely. Ventolin is available over the counter and is a short-acting bronchodilator (SA):
Salmeterol, also known as salmeterol, is used to treat both acute and chronic obstructive pulmonary disease (COPD).
Ventolin® is an asthma medicine used to treat asthma. It is available in a form of a inhaler. You may also use it on your lungs. However, the inhaler should only be used on your skin, as it can cause serious side effects. Ventolin® is a prescription medication. You can buy Ventolin® inhalers online for a lower price. The inhaler is the main brand of Ventolin®. It is also available in the form of a spray-on, inhaler, and cap. You can buy Ventolin® inhalers on the internet and order them online.
It is available in a form of a spray-on, inhaler, and cap. You can buy Ventolin® inhalers online and order them from our website.
The side effects of Ventolin® may be mild and go away on their own. However, these symptoms are usually temporary and can be managed. If you experience any severe side effects, you should stop using the inhaler. Do not use Ventolin® if you have asthma.
Stade de France Pharmacy